Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index; 7 of the 49 sources its claims cite were checked for support.

Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency

Open access

Abstract

CONTEXT: P450 oxidoreductase deficiency (PORD) is a unique congenital adrenal hyperplasia variant that manifests with glucocorticoid deficiency, disordered sex development (DSD), and skeletal malformations. No comprehensive data on genotype-phenotype correlations in Caucasian patients are available. OBJECTIVE: The objective of the study was to establish genotype-phenotype correlations in a large PORD cohort. DESIGN: The design of the study was the clinical, biochemical, and genetic assessment including multiplex ligation-dependent probe amplification (MLPA) in 30 PORD patients from 11 countries. RESULTS: We identified 23 P450 oxidoreductase (POR) mutations (14 novel) including an exonic deletion and a partial duplication detected by MLPA. Only 22% of unrelated patients carried homozygous POR mutations. p.A287P was the most common mutation (43% of unrelated alleles); no other hot spot was identified. Urinary steroid profiling showed characteristic PORD metabolomes with variable impairment of 17α-hydroxylase and 21-hydroxylase. Short cosyntropin testing revealed adrenal insufficiency in 89%. DSD was present in 15 of 18 46,XX and seven of 12 46,XY individuals. Homozygosity for p.A287P was invariably associated with 46,XX DSD but normal genitalia in 46,XY individuals. The majority of patients with mild to moderate skeletal malformations, assessed by a novel scoring system, were compound heterozygous for missense mutations, whereas nearly all patients with severe malformations carried a major loss-of-function defect on one of the affected alleles. CONCLUSIONS: We report clinical, biochemical, and genetic findings in a large PORD cohort and show that MLPA is a useful addition to POR mutation analysis. Homozygosity for the most frequent mutation in Caucasians, p.A287P, allows for prediction of genital phenotype and moderate malformations. Adrenal insufficiency is frequent, easily overlooked, but readily detected by cosyntropin testing.

Overview

CoChat Summary

TL;DR

This study reports clinical, biochemical, and genetic findings in 30 patients with P450 oxidoreductase deficiency (PORD) from 11 countries, identifying 23 POR mutations including 14 novel ones. It establishes genotype-phenotype correlations, notably that homozygous p.A287P predicts 46,XX DSD and normal male genitalia, while severe skeletal malformations are associated with a major loss-of-function allele.

Key findings

  • Among 54 unrelated alleles, p.A287P was the most common mutation, present on 23 alleles (43%); only 22% of unrelated patients carried homozygous POR mutations.
  • Adrenal insufficiency was detected by short cosyntropin testing in 24 of 27 patients (89%); 13 received permanent hydrocortisone replacement and 11 received stress-dose cover.
  • DSD occurred in 15 of 18 46,XX patients (83%) and 7 of 12 46,XY patients (58%). All four 46,XX individuals homozygous for p.A287P had 46,XX DSD, whereas both 46,XY p.A287P homozygotes had normal male external genitalia.
  • Patients with severe malformations (total malformation score 9–16) were all compound heterozygous with a null mutation on one allele; p.A287P homozygotes had mild to moderate malformations with scores between 4 and 8.

Methods

  • Clinical, biochemical, and genetic assessment was performed in 30 PORD patients (27 unrelated) from 11 countries, mostly Caucasian.
  • POR mutation analysis used direct sequencing of coding exons and exon-intron boundaries plus multiplex ligation-dependent probe amplification (MLPA); novel missense mutants were functionally tested in a microsomal yeast coexpression assay, and novel splice-site mutations were analyzed in silico.
  • Urinary steroid profiling by GC/MS measured substrate-to-product ratios reflecting 17α-hydroxylase and 21-hydroxylase activity, and a novel six-domain PORD malformation score (range 0–16) was used to grade skeletal severity.

Limitations

  • The paper states that despite MLPA, no POR mutation was detected on 11% of unrelated alleles, and no correlation was found between POR genotype and the presence or severity of glucocorticoid deficiency.
  • The paper notes that mild malformations may be overlooked and that long-term follow-up of well-characterized patients is needed to reveal the full impact of mutant POR.
  • Evident from the text: the cohort is small (n = 30) and ethnically mixed but mostly Caucasian, limiting generalizability; functional testing was performed only for selected novel missense mutants, while splice-site effects relied on in silico prediction.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/jc.2011-0640

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. Localization of POR mutations at the DNA and protein level. A, Schematic representation of the POR gene. The untranslated exon U1 is given as a black box and coding exons are numbered. Novel mutations are given in red font, and the most common mutation p.A287P in exon 8 is marked in blue. Mutations cluster in the 3′ region without any additional common mutation apart from the p.A287P mutation. The partial deletion del ex U1–1 and the partial duplication dup ex2–5 that were identified by MLPA are represented by labeled red boxes. B, Schematic representation of the POR protein. Mutant residues are located in various locations all over the three functional domains of the POR protein. C, Three-dimensional POR protein model illustrating the localization of mutant residues in relation to the three functional moieties: nicotinamide adenine dinucleotide phosphate (NADPH; blue), flavin adenine dinucleotide (FAD; yellow), and flavin mononucleotide (FMN; green). Residues affected by missense mutations are given in dark yellow, frame shift mutations in orange, and residues affected by nonsense mutations as well as an in-frame duplication are marked in red.
Fig. 1. Localization of POR mutations at the DNA and protein level. A, Schematic representation of the POR gene. The untranslated exon U1 is given as a black box and coding exons are numbered. Novel mutations are given in red font, and the most common mutation p.A287P in exon 8 is marked in blue. Mutations cluster in the 3′ region without any additional common mutation apart from the p.A287P mutation. The partial deletion del ex U1–1 and the partial duplication dup ex2–5 that were identified by MLPA are represented by labeled red boxes. B, Schematic representation of the POR protein. Mutant residues are located in various locations all over the three functional domains of the POR protein. C, Three-dimensional POR protein model illustrating the localization of mutant residues in relation to the three functional moieties: nicotinamide adenine dinucleotide phosphate (NADPH; blue), flavin adenine dinucleotide (FAD; yellow), and flavin mononucleotide (FMN; green). Residues affected by missense mutations are given in dark yellow, frame shift mutations in orange, and residues affected by nonsense mutations as well as an in-frame duplication are marked in red.CC BY-NC · PubMed Central
Fig. 2. In vivo steroidogenic enzyme activities in PORD patients (n = 23) as determined by urinary steroid profiling. Diagnostic steroid substrate over product ratios reflective of distinct steroidogenic enzyme activities and measured by GC/MS are shown in comparison with an age-matched reference cohort. Box plots represent the interquartile ranges (25th to 75th percentile), whiskers the fifth and 95th percentiles, respectively, of the reference cohort; each PORD case is represented by specific symbols.
Fig. 2. In vivo steroidogenic enzyme activities in PORD patients (n = 23) as determined by urinary steroid profiling. Diagnostic steroid substrate over product ratios reflective of distinct steroidogenic enzyme activities and measured by GC/MS are shown in comparison with an age-matched reference cohort. Box plots represent the interquartile ranges (25th to 75th percentile), whiskers the fifth and 95th percentiles, respectively, of the reference cohort; each PORD case is represented by specific symbols.CC BY-NC · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 24 Not checked · 81 Own results and interpretations

57 more claims

Create a free account to see all 111 claims and to verify the 4 references still open.

See all claims — free account
  • It may state two separate claims as one. 45
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 6 · the rest aren’t loaded

1 more finding

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 37 references

Cited by

See all 164

Metadata

Authors
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., MacDonald, F., Cole, T. R., Adolphs, N., Barton, J. S., Blair, E. M., Braddock, S. R., Collins, F., Cragun, D. L., Dattani, M. T., Day, R., Dougan, S., Feist, M., Gottschalk, M. E., Gregory, J. W., Haim, M., Harrison, R., Haskins Olney, A., Hauffa, B. P., Hindmarsh, P. C., Hopkin, R. J., Jira, P. E., Kempers, M., Kerstens, M. N., Khalifa, M. M., Köhler, B., Maiter, D., Nielsen, S., O'Riordan, S. M., Roth, C. L., Shane, K. P., Silink, M., Stikkelbroeck, N. M. M. L., Sweeney, E., Szarras-Czapnik, M., Waterson, J. R., Williamson, L., Hartmann, M. F., Taylor, N. F., Wudy, S. A., Malunowicz, E. M., Shackleton, C. H. L., & Arlt, W.
Affiliations
  • University of Birmingham (GB)
  • MRC Holland (Netherlands) (NL)
  • Birmingham Women's Hospital (GB)
  • Royal Gwent Hospital (GB)
  • National Health Service (GB)
  • Saint Louis University (US)
  • Cincinnati Children's Hospital Medical Center (US)
  • University College London (GB)
  • Kingston General Hospital (CA)
  • Altonaer Kinderkrankenhaus (DE)
  • University of California San Diego (US)
  • Cardiff University (GB)
  • Medical University of Graz (AT)
  • Nottingham University Hospitals NHS Trust (GB)
  • Essen University Hospital (DE)
  • Jeroen Bosch Ziekenhuis (NL)
  • University Medical Center Groningen (NL)
  • Akron Children's Hospital (US)
  • Charité – Universitätsmedizin Berlin (DE)
  • Cliniques Universitaires Saint-Luc (BE)
  • University of Nebraska Medical Center (US)
  • University of Washington (US)
  • Children's Hospital at Westmead (AU)
  • Radboud University Medical Center (NL)
  • University of Oklahoma Medical Center (US)
  • Justus-Liebig-Universität Gießen (DE)
  • University of London (GB)
Corresponding author
Arlt, Wiebke
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2012-02
Volume
97
Issue
2
Pages
E257-E267
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2158549435
Cited by
163
References
37
Citations by year
2026: 6 · 2025: 10 · 2024: 27 · 2023: 11 · 2022: 8 · 2021: 13 · 2020: 11 · 2019: 12 · 2018: 10 · 2017: 10 · 2016: 9 · 2015: 8 · 2014: 10 · 2013: 9 · 2012: 5
FWCI
3.24
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc)
Funders
  • Wellcome Trust (0900567, GR079865MA)
  • Medical Research Council (0900567)
  • FP7 Coordination of Non-Community Research Programmes (201444)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
P450 oxidoreductase deficiency, congenital adrenal hyperplasia, genotype-phenotype correlation, adrenal insufficiency, ACTH stimulation test, skeletal deformities, 17-hydroxylase deficiency, 21-hydroxylase deficiency, compound heterozygosity, loss-of-function mutations, Caucasian patients
MeSH terms
Adolescent, Adrenal Insufficiency, Adrenal Hyperplasia, Congenital, Adult, Child, DNA Mutational Analysis, Female, Genitalia, Humans, Male, Models, Biological, Models, Molecular, NADPH-Ferrihemoprotein Reductase, Disorders of Sex Development, Gonadal Steroid Hormones, Cohort Studies, Metabolome, Young Adult, Genetic Association Studies, Multiplex Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency. https://app.cochat.ai/papers/10.1210/jc.2011-0640
The paper
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., MacDonald, F., Cole, T. R., Adolphs, N., Barton, J. S., Blair, E. M., Braddock, S. R., Collins, F., Cragun, D. L., Dattani, M. T., . . . Arlt, W. (2012). Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2011-0640

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.